Bruker Corporation (NASDAQ: BRKR) announced new spatial biology platforms and integrated workflows at the 2026 American Association for Cancer Research Annual Meeting. The company introduced cross-platform workflows connecting its GeoMx DSP to CellScape XR and CellScape XR to CosMx SMI systems.

The company opened pre-orders for its PaintScape platform, which enables visualization of 3D genome structure in single cells. Commercial shipments are expected to begin this quarter. Bruker will offer two new panels for the platform: the ChromoPaint HuCL PanChromo MPX panel with 419-plex capability for genome-wide visualization, and the OncoPaint Oncogenic Pathways Panels with 1000+ plex capacity, available later this year.

Bruker also launched CellScape XR, a spatial proteomics platform, accepting pre-orders with commercial shipments expected this summer. The company showcased 208-plex spatial proteomics datasets developed in collaboration with University Medical Center Schleswig-Holstein, tested across 12 human tissue samples.

The CosMx SMI platform received updates including subcellular spatial imaging capabilities for mouse whole transcriptome analysis. Bruker is accepting pre-orders for the Mouse CosMx WTX system. The company also announced enhancements to its AtoMx SIP workflow system and new 3D AI-based cell segmentation models.

The GeoMx Discovery Multiomics Platform now supports simultaneous analysis of RNA pathways, proteins, and post-translational modifications. The platform can profile more than 1,200 antibodies on tissue through its Discovery Proteome Atlas.

Bruker demonstrated these technologies at AACR 2026 during a spotlight theater session on April 20 titled "Resolving Cancer Across Its Biological Layers with Single-Cell and Spatial Biology."